 | Up a level |
Papachristodoulou, Alexandros; Heidegger, Isabel; Virk, Renu K; Di Bernardo, Matteo; Kim, Jaime Y; Laplaca, Caroline; Picech, Florencia; Schäfer, Georg; De Castro, Guarionex Joel; Hibshoosh, Hanina; Loda, Massimo; Klocker, Helmut; Rubin, Mark A; Zheng, Tian; Benson, Mitchell C; McKiernan, James M; Dutta, Aditya; Abate-Shen, Cory (2024). Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. European urology, 85(4), pp. 361-372. Elsevier 10.1016/j.eururo.2023.07.016
Vasciaveo, Alessandro; Arriaga, Juan Martin; Nunes de Almeida, Francisca; Zou, Min; Douglass, Eugene F; Picech, Florencia; Shibata, Maho; Rodriguez-Calero, Antonio; de Brot, Simone; Mitrofanova, Antonina; Chua, Chee Wai; Karan, Charles; Realubit, Ronald; Pampou, Sergey; Kim, Jaime Y; Afari, Stephanie N; Mukhammadov, Timur; Zanella, Luca; Corey, Eva; Alvarez, Mariano J; ... (2023). OncoLoop: A network-based precision cancer medicine framework. Cancer discovery, 13(2), pp. 386-409. American Association for Cancer Research 10.1158/2159-8290.CD-22-0342
Papachristodoulou, Alexandros; Rodríguez-Calero, Antonio; Panja, Sukanya; Margolskee, Elizabeth; Virk, Renu K; Milner, Teresa A; Martina, Luis Pina; Kim, Jaime Y; Di Bernardo, Matteo; Williams, Alanna B; Maliza, Elvis A; Caputo, Joseph M; Haas, Christopher; Wang, Vinson; De Castro, Guarionex Joel; Wenske, Sven; Hibshoosh, Hanina; McKiernan, James M; Shen, Michael M; Rubin, Mark A; ... (2021). NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation. Cancer discovery, 11(9), pp. 2316-2333. American Association for Cancer Research 10.1158/2159-8290.CD-20-1765
Arriaga, Juan M.; Panja, Sukanya; Alshalalfa, Mohammed; Zhao, Junfei; Zou, Min; Giacobbe, Arianna; Madubata, Chioma J.; Kim, Jaime Yeji; Rodriguez, Antonio; Coleman, Ilsa; Virk, Renu K.; Hibshoosh, Hanina; Ertunc, Onur; Ozbek, Büşra; Fountain, Julia; Jeffrey Karnes, R.; Luo, Jun; Antonarakis, Emmanuel S.; Nelson, Peter S.; Feng, Felix Y.; ... (2020). A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance. Nature ancer, 1(11), pp. 1082-1096. Springer Nature 10.1038/s43018-020-00125-0
Zou, Min; Toivanen, Roxanne; Mitrofanova, Antonina; Floch, Nicolas; Hayati, Sheida; Sun, Yanping; Le Magnen, Clémentine; Chester, Daniel; Mostaghel, Elahe A; Califano, Andrea; Rubin, Mark Andrew; Shen, Michael M; Abate-Shen, Cory (2017). Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer. Cancer discovery, 7(7), pp. 736-749. American Association for Cancer Research 10.1158/2159-8290.CD-16-1174
Li, Jia J; Vasciaveo, Alessandro; Karagiannis, Dimitrios; Sun, Zhen; Chen, Xiao; Socciarelli, Fabio; Frankenstein, Ziv; Zou, Min; Pannellini, Tania; Chen, Yu; Gardner, Kevin; Robinson, Brian D; de Bono, Johann; Abate-Shen, Cory; Rubin, Mark A.; Loda, Massimo; Sawyers, Charles L; Califano, Andrea; Lu, Chao and Shen, Michael M (19 July 2023). NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer. (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2023.07.18.549585
